Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome

Circulation

Volumn 104, Issue 22, 2001, Pages 2722-2727

  Van Opstal, Jurren M ^a   Schoenmakers, Marieke ^a   Verduyn, S Cora ^a   De Groot, S H Marieke ^a   Leunissen, Jet D M ^a   Van Der Hulst, Ferenc F ^a   Molenschot, Mirella M C ^a   Wellens, Hein J J ^a   Vos, Marc A ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Action potentials; Antiarrhythmia agents; Electrophysiology; Hypertrophy

Indexed keywords

ADRENALIN; AMIODARONE; ANTIARRHYTHMIC AGENT; DRONEDARONE;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATRIOVENTRICULAR BLOCK; CHRONOPHARMACOLOGY; CONTROLLED STUDY; DOG; DRUG EFFECT; ELECTROCARDIOGRAM; EXTRASYSTOLE; FEMALE; HEART DEPOLARIZATION; HEART ELECTROPHYSIOLOGY; LONG QT SYNDROME; MALE; NONHUMAN; PRIORITY JOURNAL; QT INTERVAL; TORSADE DES POINTES;

EID: 0035960660     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc4701.099579     Document Type: Article

References (31)

1. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia: Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure
2. Proarrhythmia with class III antiarrhythmic drugs: Definition, electrophysiologic mechanisms, incidence, predisposing factors, and clinical implications
3. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators
4. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators
5. The historical development, cellular electrophysiology and pharmacology of amiodarone
6. Adverse effects of low dose amiodarone: A meta-analysis
7. SR 33589, a new amiodarone-like antiarrhythmic agent: Electrophysiological effects in anesthetized dogs
8. Electrophysiological effects of dronedarone (SR33589), a noniodinated benzofuran derivative, in the rabbit heart: Comparison with amiodarone
9. Hemodynamic and antiadrenergic effects of dronedarone and amiodarone in animals with a healed myocardial infarction
10. Further observations to elucidate the role of interventricular dispersion of repolarization and early afterdepolarizations in the genesis of acquired torsade de pointes arrhythmias: A comparison between almokalant and d-sotalol using the dog as its own control
11. Enhanced susceptibility for acquired torsade de pointes arrhythmias in the dog with chronic, complete AV block is related to cardiac hypertrophy and electrical remodeling
12. Evaluation of the acute electrophysiologic effects of intravenous dronedarone, an amiodarone-like agent, with special emphasis on ventricular repolarization and acquired torsade de pointes arrhythmias
13. Early afterdepolarizations in the in situ canine heart: Mechanistic insights into acquired torsade de pointes arrhythmias
14. Time course of structural adaptations in chronic AV block dogs: Evidence for differential ventricular remodeling
15. Azimilide and dofetilide produce similar electrophysiological and proarrhythmic effects in a canine model of torsade de pointes arrhythmias
16. Electrophysiological parameters indicative of sudden cardiac death in the dog with chronic complete AV-block
17. Chronic amiodarone reduces transmural dispersion of repolarization in the canine heart
18. An improved method to correct the QT interval of the electrocardiogram for changes in heart rate
19. Myocardial disposition of amiodarone in the dog
20. Effects of chronic treatment by amiodarone on transmural heterogeneity of canine ventricular repolarization in vivo: Interactions with acute sotalol
21. Electropharmacology of amiodarone therapy initiation: Time courses of onset of electrophysiologic and antiarrhythmic effects
22. Cellular electropharmacology of amiodarone
23. Amiodarone in patients with previous drug-mediated torsade de pointes: Long-term safety and efficacy
24. Frequency-dependent electrophysiologic effects of amiodarone in humans
25. Electrophysiologic substrate of torsade de pointes: Dispersion of repolarization or early afterdepolarizations?
26. Progress in the understanding of cardiac early afterdepolarizations and torsades de pointes: Time to revise current concepts
27. Observations on the onset of torsade de pointes arrhythmias in the acquired long QT syndrome
28. Modulated dispersion explains changes in arrhythmia vulnerability during premature stimulation of the heart
29. The long QT syndrome and torsade de pointes
30. Amiodarone reduces transmural heterogeneity of repolarization in the human heart
31. Acute and chronic effects of amiodarone on delayed afterdepolarization and triggered automaticity in rabbit ventricular myocardium